Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Anatomie hoofdstuk lezen eerste hoofdstuk lezen

2017 | OriginalPaper | Hoofdstuk

10. Placenta accreta, increta en percreta

Auteurs : W. Mingelen, F. M. van Dunné, P. J. Dörr

Gepubliceerd in: Obstetrische interventies

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Bij een placenta accreta, increta of percreta ontbreekt de decidua van het endometrium waardoor de placenta gedeeltelijk of geheel direct in het myometrium insereert (placenta accreta; figuur 10.1A), invadeert in het myometrium (placenta increta; figuur 10.1B) of door het myometrium heen groeit in omringende structuren en organen (placenta percreta; figuur 10.1C).
vorige hoofdstuk Retentio placentae
volgende hoofdstuk Inversio uteri
Literatuur
1.
American College of Obstetricians and Gynecologists. Placenta accreta. ACOG. 2012;529:207-11.
2.
O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175:1632-38.CrossRef
3.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458-61.CrossRef
4.
Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210-4.CrossRef
5.
Higgins MF, Monteith C, Foley M, O’Herlihy C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 2013;171:54-6.CrossRef
6.
Morlando M, Sarno L, Napolitano R, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92:457-60.CrossRef
7.
Al-Serehi A, Mhoyan Q, Brown M, et al. Placenta accreta: an association with fibroids and Asherman syndrome. J Ultrasound Med. 2008;27:1623-8.CrossRef
8.
Hamar BD, Wolff EF, Kodaman PH, et al. Premature rupture of membranes, placenta increta and hysterectomy in a pregnancy following endometrial ablation. J Perinatol. 2006;26:135-7.CrossRef
9.
Pron G, Mocarski E, Bennet J, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;26:89-96.
10.
Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226-32.
11.
Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208:219.e1-7.
12.
Kamara M, Henderson JJ, Doherty DA, et al. The risk of placenta accreta following primary elective caesarean delivery: a case-controle study. BJOG. 2013;120:879-86.CrossRef
13.
Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. RCOG Green-top Guideline No. 27. 2011.
14.
Calì G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol. 2013;41:406-12.CrossRef
15.
D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42:509-17.CrossRef
16.
Shih JC, Palacios Jaraquemada JM, Su YN, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol. 2009;33:193-203.CrossRef
17.
Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005;26:89-96.CrossRef
18.
Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108:573-81.CrossRef
19.
Dwyer BK, Belogolovin V, Tran L, et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med. 2008;27:1275-81.CrossRef
20.
Masseli G, Brunelli R, Casciani E, et al. Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol. 2008;18:1292-9.CrossRef
21.
American College of Obstetricians and Gynecologists. Anemia in pregnancy. ACOG Practice Bull. 2008;112:201-7.
22.
Eller AG, Porter TF, Soisson P, et al. Optimal management strategies for placenta accreta. BJOG. 2009;116:648-54.CrossRef
23.
Stutchfield P, Whitaker R, Russell I; Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005;331:662.CrossRef
24.
Royal College of Obstetricians and Gynaecologists. Green-top Guideline No.7: Antenatal corticosteroids to reduce neonatal morbidity and mortality. Londen: RCOG, 2010.
25.
Rao KP, Belogolovkin V, Yankowitz Y, et al. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta and vasa previa. Obstet Gynecol Surv. 2012;67:503-19.CrossRef
26.
Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117:331-7.CrossRef
27.
Hoffman MS, Karlnoski RA, Mangar D, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol. 2010;202:628.e1-628.e5.CrossRef
28.
Kato R, Terui K, Yokota K, et al. Anesthetic management for cases of placenta accreta presented for cesarean section: a 7-year single-center experience [artikel in het Japans; Engels abstract]. Masui. 2008;57:1421-6.
29.
30.
Timmermans S, Hof AC van, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007;62:529-39.CrossRef
31.
Bretelle F, Courbiere B, Mazouni C, et al. Management of placenta accreta: Morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007;133:34-9.
32.
Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526-34.CrossRef
33.
Arulkumaran S, Ng CS, Ingemarsson I, et al. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand. 1986;65:285-86.CrossRef
34.
Winick M, Coscia A, Noble A. Cellular growth in human placenta. Normal placental growth. Pediatrics. 1967;39:248-51.
35.
Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25:2803-10.CrossRef
36.
Kayem G, Clement D, Goffinet F. Recurrence following conservative management of placenta accreta. Int J Gynecol Obstet. 2007;99:142-3.CrossRef
Metagegevens
Titel
Placenta accreta, increta en percreta
Auteurs
W. Mingelen
F. M. van Dunné
P. J. Dörr
Copyright
2017
Uitgeverij
Bohn Stafleu van Loghum
Boek
Obstetrische interventies

Print ISBN: 978-90-368-1743-1

Elektronisch ISBN: 978-90-368-1744-8

Copyright: 2017

DOI
https://doi.org/10.1007/978-90-368-1744-8_10